Matches in SemOpenAlex for { <https://semopenalex.org/work/W2411356132> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W2411356132 endingPage "63" @default.
- W2411356132 startingPage "658" @default.
- W2411356132 abstract "To determine whether expression of CD20 is associated with clinical outcomes of childhood B-cell precursor acute lymphoblastic leukemia (BCP-ALL).271 newly diagnosed childhood BCP-ALL during January 2009 to May 2013 were enrolled in this study. The patients were treated in line with the Chinese Childhood Leukemia Group ALL 2008 protocol (CCLG-ALL 2008). The clinical feature, early therapeutic response and clinical outcomes of the patients with a CD20 positive (CD20+ BCP) expression were compared with those with a CD20 negative (CD20- BCP) expression.CD20- BCP accounted for 45.76% (124 cases) of all participants. There were no significant differences between CD20- BCP and CD20- BCP patients in gender distribution, age, WBC counts when diagnosis was made, proportion of prednisone poor responders, and distribution of risk categories (P > 0.05). Patients of 10 years or older comprised 25.81% and 14.29% of CD20+ BCP and CD20- BCP patients, respectively (P = 0.017). Pro-B and pre-B cases accounted for 43.55% and 59.86% of CD20- BCP patients respectively, compared with 56.45 and 40.14% in CD20- BCP patients (P = 0.007). CD20+ BCP patients had 12.20% Philadelphia positive ALL and 6.50% BCP-ALL with TEL-AML1 fusion gene, compared with 4.86% (P = 0.03) and 18.06% (P = 0.005) in those of CD20 BCP. No significant differences were found between the two groups of patients in 15-day (77.50% vs. 74.13%, P = 0.525) and 33-day (95.04% vs. 95.83%, P = 0.757) complete remission rates. No significant differences (P > 0.05) were found in predicted 4-year event-free survival CEFS (78.00% +/- 4.96%) vs. (79.05% +/- 5.40%)) and predicted 4-year overall survival (OS (83.01% +/- 6.13%) vs. (93.64% +/- 2.46%)) between the two groups of patients either.CD20 positivity was not found to be associated with worse prognosis of children with BCP-ALL. More studies are needed to validate the correlation between CD20 and unfavorable outcomes in BCP-ALL." @default.
- W2411356132 created "2016-06-24" @default.
- W2411356132 creator A5003150993 @default.
- W2411356132 creator A5005303316 @default.
- W2411356132 creator A5040732722 @default.
- W2411356132 creator A5045479972 @default.
- W2411356132 creator A5057459795 @default.
- W2411356132 creator A5059090336 @default.
- W2411356132 creator A5066001887 @default.
- W2411356132 creator A5072819130 @default.
- W2411356132 creator A5074903549 @default.
- W2411356132 creator A5087179754 @default.
- W2411356132 date "2014-07-01" @default.
- W2411356132 modified "2023-10-16" @default.
- W2411356132 title "[Expression of CD20 in B-cell precursor acute lymphoblastic leukemia and its correlation with clinical outcomes]." @default.
- W2411356132 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25286695" @default.
- W2411356132 hasPublicationYear "2014" @default.
- W2411356132 type Work @default.
- W2411356132 sameAs 2411356132 @default.
- W2411356132 citedByCount "0" @default.
- W2411356132 crossrefType "journal-article" @default.
- W2411356132 hasAuthorship W2411356132A5003150993 @default.
- W2411356132 hasAuthorship W2411356132A5005303316 @default.
- W2411356132 hasAuthorship W2411356132A5040732722 @default.
- W2411356132 hasAuthorship W2411356132A5045479972 @default.
- W2411356132 hasAuthorship W2411356132A5057459795 @default.
- W2411356132 hasAuthorship W2411356132A5059090336 @default.
- W2411356132 hasAuthorship W2411356132A5066001887 @default.
- W2411356132 hasAuthorship W2411356132A5072819130 @default.
- W2411356132 hasAuthorship W2411356132A5074903549 @default.
- W2411356132 hasAuthorship W2411356132A5087179754 @default.
- W2411356132 hasConcept C126322002 @default.
- W2411356132 hasConcept C159654299 @default.
- W2411356132 hasConcept C18031839 @default.
- W2411356132 hasConcept C203014093 @default.
- W2411356132 hasConcept C2778453870 @default.
- W2411356132 hasConcept C2778461978 @default.
- W2411356132 hasConcept C2778720950 @default.
- W2411356132 hasConcept C2779338263 @default.
- W2411356132 hasConcept C2909962599 @default.
- W2411356132 hasConcept C71924100 @default.
- W2411356132 hasConcept C90924648 @default.
- W2411356132 hasConceptScore W2411356132C126322002 @default.
- W2411356132 hasConceptScore W2411356132C159654299 @default.
- W2411356132 hasConceptScore W2411356132C18031839 @default.
- W2411356132 hasConceptScore W2411356132C203014093 @default.
- W2411356132 hasConceptScore W2411356132C2778453870 @default.
- W2411356132 hasConceptScore W2411356132C2778461978 @default.
- W2411356132 hasConceptScore W2411356132C2778720950 @default.
- W2411356132 hasConceptScore W2411356132C2779338263 @default.
- W2411356132 hasConceptScore W2411356132C2909962599 @default.
- W2411356132 hasConceptScore W2411356132C71924100 @default.
- W2411356132 hasConceptScore W2411356132C90924648 @default.
- W2411356132 hasIssue "4" @default.
- W2411356132 hasLocation W24113561321 @default.
- W2411356132 hasOpenAccess W2411356132 @default.
- W2411356132 hasPrimaryLocation W24113561321 @default.
- W2411356132 hasRelatedWork W1511775759 @default.
- W2411356132 hasRelatedWork W1994891665 @default.
- W2411356132 hasRelatedWork W2010472409 @default.
- W2411356132 hasRelatedWork W2039600829 @default.
- W2411356132 hasRelatedWork W2410889947 @default.
- W2411356132 hasRelatedWork W2411733815 @default.
- W2411356132 hasRelatedWork W2413769595 @default.
- W2411356132 hasRelatedWork W2428264021 @default.
- W2411356132 hasRelatedWork W2434462282 @default.
- W2411356132 hasRelatedWork W2438238198 @default.
- W2411356132 hasVolume "45" @default.
- W2411356132 isParatext "false" @default.
- W2411356132 isRetracted "false" @default.
- W2411356132 magId "2411356132" @default.
- W2411356132 workType "article" @default.